{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T07:13:58Z","timestamp":1790320438029,"version":"4.1.0"},"reference-count":105,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001775","name":"University of Technology Sydney","doi-asserted-by":"publisher","award":["PhD stipend scholarship"],"award-info":[{"award-number":["PhD stipend scholarship"]}],"id":[{"id":"10.13039\/501100001775","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1007\/s00415-021-10461-5","type":"journal-article","created":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T22:02:42Z","timestamp":1614636162000},"page":"676-692","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Genetic counseling and testing practices for late-onset neurodegenerative disease: a systematic review"],"prefix":"10.1007","volume":"269","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5578-0460","authenticated-orcid":false,"given":"Ashley","family":"Crook","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9557-9080","authenticated-orcid":false,"given":"Chris","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4219-4985","authenticated-orcid":false,"given":"Toby","family":"Newton-John","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9186-1644","authenticated-orcid":false,"given":"Rosie","family":"O\u2019Shea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8705-1190","authenticated-orcid":false,"given":"Alison","family":"McEwen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,1]]},"reference":[{"issue":"3","key":"10461_CR1","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1055\/s-2008-1040841","volume":"19","author":"TD Bird","year":"1999","unstructured":"Bird TD (1999) Risks and benefits of DNA testing for neurogenetic disorders. Semin Neurol 19(3):253\u2013259. https:\/\/doi.org\/10.1055\/s-2008-1040841","journal-title":"Semin Neurol"},{"issue":"5","key":"10461_CR2","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1007\/s40291-018-0347-7","volume":"22","author":"JS Goldman","year":"2018","unstructured":"Goldman JS, Van Deerlin VM (2018) Alzheimer\u2019s disease and frontotemporal dementia: the current state of genetics and genetic testing since the advent of next-generation sequencing. Mol Diagn Ther 22(5):505\u2013513. https:\/\/doi.org\/10.1007\/s40291-018-0347-7","journal-title":"Mol Diagn Ther"},{"issue":"1","key":"10461_CR3","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/bmb\/ldy008","volume":"126","author":"C Patch","year":"2018","unstructured":"Patch C, Middleton A (2018) Genetic counselling in the era of genomic medicine. Br Med Bull 126(1):27\u201336. https:\/\/doi.org\/10.1093\/bmb\/ldy008","journal-title":"Br Med Bull"},{"key":"10461_CR4","unstructured":"Human Genetics Society of Australasia (2015) Guideline: Process of Genetic Counseling. Australia"},{"issue":"2","key":"10461_CR5","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s10897-005-9014-3","volume":"15","author":"R Resta","year":"2006","unstructured":"Resta R, Biesecker BB, Bennett RL, Blum S, Estabrooks Hahn S, Strecker MN, Williams JL (2006) A new definition of genetic counseling: national society of genetic counselors\u2019 task force report. J Genet Couns 15(2):77\u201383. https:\/\/doi.org\/10.1007\/s10897-005-9014-3","journal-title":"J Genet Couns"},{"issue":"2","key":"10461_CR6","first-page":"240","volume":"27","author":"Ad Hoc Committee on Genetic Counseling ASoHG","year":"1975","unstructured":"Ad Hoc Committee on Genetic Counseling ASoHG (1975) Genetic counseling. Am J Hum Gen 27(2):240\u2013242","journal-title":"Am J Hum Gen"},{"key":"10461_CR7","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1002\/ajmg.c.31607","volume":"1","author":"KE Ormond","year":"2018","unstructured":"Ormond KE, Laurino MY, Barlow-Stewart K, Wessels TM, Macaulay S, Austin J, Middleton A (2018) Genetic counseling globally: where are we now? Am J Med Genet C Semin Med Genet 1:98\u2013107","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"10461_CR8","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1038\/s41436-020-0785-6","volume":"22","author":"S White","year":"2020","unstructured":"White S, Jacobs C, Phillips J (2020) Mainstreaming genetics and genomics: a systematic review of the barriers and facilitators for nurses and physicians in secondary and tertiary care. Genet Med 22:1149\u20131155. https:\/\/doi.org\/10.1038\/s41436-020-0785-6","journal-title":"Genet Med"},{"issue":"3","key":"10461_CR9","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1111\/j.1399-0004.2012.01900.x","volume":"83","author":"R MacLeod","year":"2013","unstructured":"MacLeod R, Tibben A, Frontali M, Evers-Kiebooms G, Jones A, Martinez-Descales A, Roos RA, Editorial C, Working Group \u201cGenetic Testing Counselling\u201d of the European Huntington Disease N (2013) Recommendations for the predictive genetic test in Huntington\u2019s disease. Clin Genet 83(3):221\u2013231. https:\/\/doi.org\/10.1111\/j.1399-0004.2012.01900.x","journal-title":"Clin Genet"},{"issue":"3","key":"10461_CR10","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1038\/ejhg.2012.174","volume":"21","author":"H Skirton","year":"2013","unstructured":"Skirton H, Goldsmith L, Jackson L, Tibben A (2013) Quality in genetic counselling for presymptomatic testing\u2014clinical guidelines for practice across the range of genetic conditions. Eur J Hum Genet 21(3):256\u2013260. https:\/\/doi.org\/10.1038\/ejhg.2012.174","journal-title":"Eur J Hum Genet"},{"issue":"3","key":"10461_CR11","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1111\/j.1468-1331.2011.03501.x","volume":"19","author":"PM Andersen","year":"2012","unstructured":"Andersen PM, Abrahams S, Borasio GD, de Carvalho M, Chio A, Van Damme P, Hardiman O, Kollewe K, Morrison KE, Petri S, Pradat PF, Silani V, Tomik B, Wasner M, Weber M (2012) EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS)\u2014revised report of an EFNS task force. Eur J Neurol 19(3):360\u2013375. https:\/\/doi.org\/10.1111\/j.1468-1331.2011.03501.x","journal-title":"Eur J Neurol"},{"issue":"9","key":"10461_CR12","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1111\/j.1468-1331.2012.03784.x","volume":"19","author":"S Sorbi","year":"2012","unstructured":"Sorbi S, Hort J, Erkinjuntti T, Fladby T, Gainotti G, Gurvit H, Nacmias B, Pasquier F, Popescu BO, Rektorova I, Religa D, Rusina R, Rossor M, Schmidt R, Stefanova E, Warren JD, Scheltens P (2012) EFNS-ENS Guidelines on the diagnosis and management of disorders associated with dementia. Eur J Neurol 19(9):1159\u20131179. https:\/\/doi.org\/10.1111\/j.1468-1331.2012.03784.x","journal-title":"Eur J Neurol"},{"issue":"1","key":"10461_CR13","doi-asserted-by":"publisher","first-page":"277","DOI":"10.3233\/JAD-150849","volume":"51","author":"M Bocchetta","year":"2016","unstructured":"Bocchetta M, Mega A, Bernardi L, Di Maria E, Benussi L, Binetti G, Borroni B, Colao R, Di Fede G, Fostinelli S (2016) genetic counseling and testing for Alzheimer\u2019s disease and frontotemporal lobar degeneration: an italian consensus protocol. J Alzheimers Dis 51(1):277\u2013291","journal-title":"J Alzheimers Dis"},{"issue":"6","key":"10461_CR14","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1097\/GIM.0b013e31821d69b8","volume":"13","author":"JS Goldman","year":"2011","unstructured":"Goldman JS, Hahn SE, Catania JW, LaRusse-Eckert S, Butson MB, Rumbaugh M, Strecker MN, Roberts JS, Burke W, Mayeux R, Bird T, American College of Medical G, the National Society of Genetic C (2011) Genetic counseling and testing for Alzheimer disease: joint practice guidelines of the American College of Medical Genetics and the National Society of Genetic Counselors. Genet Med 13(6):597\u2013605. https:\/\/doi.org\/10.1097\/GIM.0b013e31821d69b8","journal-title":"Genet Med"},{"issue":"1","key":"10461_CR15","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1136\/practneurol-2013-000790","volume":"15","author":"D Craufurd","year":"2015","unstructured":"Craufurd D, MacLeod R, Frontali M, Quarrell O, Bijlsma EK, Davis M, Hjermind LE, Lahiri N, Mandich P, Martinez A, Tibben A, Roos RA, Working Group on Genetic C, Testing of the European Huntington\u2019s Disease N (2015) Diagnostic genetic testing for Huntington\u2019s disease. Pract Neurol 15(1):80\u201384. https:\/\/doi.org\/10.1136\/practneurol-2013-000790","journal-title":"Pract Neurol"},{"issue":"8","key":"10461_CR16","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1212\/WNL.44.8.1533","volume":"44","author":"International Huntington Association (IHA) and the World Federation of Neurology (WFN) Research Group on Huntington's Chorea","year":"1994","unstructured":"International Huntington Association (IHA) and the World Federation of Neurology (WFN) Research Group on Huntington\u2019s Chorea (1994) Guidelines for the molecular genetics predictive test in Huntington\u2019s disease. Neurology 44(8):1533\u20131536","journal-title":"Neurology"},{"issue":"7","key":"10461_CR17","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1136\/jmg.31.7.555","volume":"31","author":"International Huntington Association (IHA) and the World Federation of Neurology (WFN) Research Group on Huntington's Chorea","year":"1994","unstructured":"International Huntington Association (IHA) and the World Federation of Neurology (WFN) Research Group on Huntington\u2019s Chorea (1994) Guidelines for the molecular genetics predictive test in Huntington\u2019s disease. J Med Genet 31(7):555\u2013559. https:\/\/doi.org\/10.1136\/jmg.31.7.555","journal-title":"J Med Genet"},{"issue":"8 Suppl 2","key":"10461_CR18","first-page":"II2","volume":"39","author":"JM Grimshaw","year":"2001","unstructured":"Grimshaw JM, Shirran L, Thomas R, Mowatt G, Fraser C, Bero L, Grilli R, Harvey E, Oxman A, O\u2019Brien MA (2001) Changing provider behavior: an overview of systematic reviews of interventions. Med Care 39(8 Suppl 2):II2\u2013II45","journal-title":"Med Care"},{"issue":"9391","key":"10461_CR19","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1016\/s0140-6736(03)14546-1","volume":"362","author":"R Grol","year":"2003","unstructured":"Grol R, Grimshaw J (2003) From best evidence to best practice: effective implementation of change in patients\u2019 care. Lancet 362(9391):1225\u20131230. https:\/\/doi.org\/10.1016\/s0140-6736(03)14546-1","journal-title":"Lancet"},{"issue":"4","key":"10461_CR20","doi-asserted-by":"publisher","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","volume":"151","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 151(4):264\u2013269","journal-title":"Ann Intern Med"},{"issue":"3","key":"10461_CR21","doi-asserted-by":"publisher","first-page":"276","DOI":"10.11613\/BM.2012.031","volume":"22","author":"ML McHugh","year":"2012","unstructured":"McHugh ML (2012) Interrater reliability: the kappa statistic. Biochem Med (Zagreb) 22(3):276\u2013282","journal-title":"Biochem Med (Zagreb)"},{"issue":"5","key":"10461_CR22","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/0895-4356(93)90018-V","volume":"46","author":"T Byrt","year":"1993","unstructured":"Byrt T, Bishop J, Carlin JB (1993) Bias, prevalence and kappa. J Clin Epidemiol 46(5):423\u2013429. https:\/\/doi.org\/10.1016\/0895-4356(93)90018-V","journal-title":"J Clin Epidemiol"},{"key":"10461_CR23","unstructured":"Kmet LM, Lee RC, Research AHFfM, Cook LS (2004) Standard Quality Assessment Criteria for Evaluating primary research papers from a variety of fields. Alberta Heritage Foundation for Medical Research, Edmonton"},{"key":"10461_CR24","volume-title":"Guidance on the conduct of narrative synthesis in systematic reviews: a product from the ESRC methods programme (Version I)","author":"J Popay","year":"2006","unstructured":"Popay J, Roberts H, Sowden A, Petticrew M, Arai L, Rodgers M, Britten N, Roen K, Duffy S (2006) Guidance on the conduct of narrative synthesis in systematic reviews: a product from the ESRC methods programme (Version I). University of Lancaster, Lancaster, UK"},{"issue":"3","key":"10461_CR25","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1177\/1742395311403637","volume":"7","author":"H Etchegary","year":"2011","unstructured":"Etchegary H (2011) Healthcare experiences of families affected by Huntington disease: need for improved care. Chronic IIln 7(3):225\u2013238. https:\/\/doi.org\/10.1177\/1742395311403637","journal-title":"Chronic IIln"},{"issue":"2","key":"10461_CR26","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1177\/0969733012452686","volume":"20","author":"PL Andersson","year":"2013","unstructured":"Andersson PL, Juth N, Petersen A, Graff C, Edberg A-K (2013) Ethical aspects of undergoing a predictive genetic testing for Huntington\u2019s disease. Nurs Ethics 20(2):189\u2013199. https:\/\/doi.org\/10.1177\/0969733012452686","journal-title":"Nurs Ethics"},{"issue":"10","key":"10461_CR27","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1007\/s00415-012-6468-8","volume":"259","author":"S Reyes","year":"2012","unstructured":"Reyes S, Kurtz A, Herve D, Tournier-Lasserve E, Chabriat H (2012) Presymptomatic genetic testing in CADASIL. J Neurol 259(10):2131\u20132136. https:\/\/doi.org\/10.1007\/s00415-012-6468-8","journal-title":"J Neurol"},{"issue":"5","key":"10461_CR28","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1177\/0969733015576356","volume":"23","author":"PL Andersson","year":"2016","unstructured":"Andersson PL, Petersen A, Graff C, Edberg A-K (2016) Ethical aspects of a predictive test for Huntington\u2019s Disease: a long term perspective. Nurs Ethics 23(5):565\u2013575. https:\/\/doi.org\/10.1177\/0969733015576356","journal-title":"Nurs Ethics"},{"issue":"7\u20138","key":"10461_CR29","first-page":"385","volume":"59","author":"R Klitzman","year":"2014","unstructured":"Klitzman R, Abbate KJ, Chung WK, Ottman R, Leu C-S, Appelbaum PS (2014) Views of preimplantation genetic diagnosis among psychiatrists and neurologists. J Reprod Med 59(7\u20138):385\u2013392","journal-title":"J Reprod Med"},{"issue":"1","key":"10461_CR30","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1159\/000315033","volume":"64","author":"C Mariotti","year":"2010","unstructured":"Mariotti C, Ferruta A, Gellera C, Nespolo C, Fancellu R, Genitrini S, Di Bella D, Panzeri M, Nanetti L, Tomasello C, Taroni F, Foresti G, Astori S (2010) Predictive genetic tests in neurodegenerative disorders: a methodological approach integrating psychological counseling for at-risk individuals and referring clinicians. Eur Neurol 64(1):33\u201341. https:\/\/doi.org\/10.1159\/000315033","journal-title":"Eur Neurol"},{"issue":"6","key":"10461_CR31","doi-asserted-by":"publisher","first-page":"534","DOI":"10.5114\/ninp.2013.39070","volume":"47","author":"T Uhrova","year":"2013","unstructured":"Uhrova T, Zidovska J, Koblihova J, Klempir J, Majerova V, Roth J (2013) Importance of psychiatric examination in predictive genetic testing for Huntington disease. Neurol Neurochir Pol 47(6):534\u2013541","journal-title":"Neurol Neurochir Pol"},{"key":"10461_CR32","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1038\/s41431-020-0633-9","volume":"28","author":"M Oosterloo","year":"2020","unstructured":"Oosterloo M, Bijlsma EK, Verschuuren-Bemelmans CC, Schouten MI, de Die-Smulders C, Roos RAC (2020) Predictive genetic testing in Huntington\u2019s disease: should a neurologist be involved? Eur J Hum Genet 28:1205\u20131209. https:\/\/doi.org\/10.1038\/s41431-020-0633-9","journal-title":"Eur J Hum Genet"},{"issue":"4","key":"10461_CR33","doi-asserted-by":"publisher","first-page":"295","DOI":"10.20344\/amp.10526","volume":"32","author":"M Paneque","year":"2019","unstructured":"Paneque M, Felix J, Mendes A, Lemos C, Ledo S, Silva J, Sequeiros J (2019) Twenty years of a pre-symptomatic testing protocol for late-onset neurological diseases in Portugal. Acta Med Port 32(4):295\u2013304","journal-title":"Acta Med Port"},{"key":"10461_CR34","doi-asserted-by":"publisher","first-page":"e002227","DOI":"10.1136\/bmjopen-2012-002227","volume":"3","author":"MJ Esplen","year":"2013","unstructured":"Esplen MJ, Cappelli M, Wong J, Bottorff JL, Hunter J, Carroll J, Dorval M, Wilson B, Allanson J, Semotiuk K, Aronson M, Bordeleau L, Charlemagne N, Meschino W (2013) Development and validation of a brief screening instrument for psychosocial risk associated with genetic testing: a pan-Canadian cohort study. BMJ open 3:e002227. https:\/\/doi.org\/10.1136\/bmjopen-2012-002227","journal-title":"BMJ open"},{"issue":"10","key":"10461_CR35","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.ejmg.2018.03.010","volume":"61","author":"S Ledo","year":"2018","unstructured":"Ledo S, Ramires A, Leite A, Dinis MAP, Sequeiros J (2018) Long-term predictors for psychological outcome of pre-symptomatic testing for late-onset neurological diseases. Eur J Med Genet 61(10):575\u2013580. https:\/\/doi.org\/10.1016\/j.ejmg.2018.03.010","journal-title":"Eur J Med Genet"},{"issue":"6","key":"10461_CR36","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1002\/mgg3.494","volume":"6","author":"K Stuttgen","year":"2018","unstructured":"Stuttgen K, Dvoskin R, Bollinger J, McCague A, Shpritz B, Brandt J, Mathews D (2018) Risk perception before and after presymptomatic genetic testing for Huntington\u2019s disease: Not always what one might expect. Mol Genet Genomic Med 6(6):1140\u20131147. https:\/\/doi.org\/10.1002\/mgg3.494","journal-title":"Mol Genet Genomic Med"},{"issue":"5","key":"10461_CR37","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1007\/s10897-010-9307-z","volume":"19","author":"R Klitzman","year":"2010","unstructured":"Klitzman R (2010) Misunderstandings concerning genetics among patients confronting genetic disease. J Genet Couns 19(5):430\u2013446. https:\/\/doi.org\/10.1007\/s10897-010-9307-z","journal-title":"J Genet Couns"},{"issue":"12","key":"10461_CR38","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1089\/gtmb.2011.0370","volume":"16","author":"C Gonzalez","year":"2012","unstructured":"Gonzalez C, Gomes E, Kazachkova N, Bettencourt C, Raposo M, Kay TT, MacLeod P, Vasconcelos J, Lima M (2012) Psychological well-being and family satisfaction levels five years after being confirmed as a carrier of the Machado-Joseph disease mutation. Genet Test Mol Biomarkers 16(12):1363\u20131368. https:\/\/doi.org\/10.1089\/gtmb.2011.0370","journal-title":"Genet Test Mol Biomarkers"},{"issue":"3","key":"10461_CR39","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s10897-010-9347-4","volume":"20","author":"T Cruz Marino","year":"2011","unstructured":"Cruz Marino T, Reynaldo Arminan R, Cedeno HJ, Laffita Mesa JM, Gonzalez Zaldivar Y, Aguilera Rodriguez R, Velazquez Santos M, Almaguer Mederos LE, Paneque Herrera M, Velazquez Perez L (2011) Ethical dilemmas in genetic testing: examples from the Cuban program for predictive diagnosis of hereditary ataxias. J Genet Couns 20(3):241\u2013248. https:\/\/doi.org\/10.1007\/s10897-010-9347-4","journal-title":"J Genet Couns"},{"issue":"1","key":"10461_CR40","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1111\/cge.12033","volume":"84","author":"AK Hawkins","year":"2013","unstructured":"Hawkins AK, Creighton S, Ho A, McManus B, Hayden MR (2013) Providing predictive testing for Huntington disease via telehealth: results of a pilot study in British Columbia, Canada. Clin Genet 84(1):60\u201364. https:\/\/doi.org\/10.1111\/cge.12033","journal-title":"Clin Genet"},{"issue":"4","key":"10461_CR41","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.ymgme.2010.12.001","volume":"102","author":"S Dufrasne","year":"2011","unstructured":"Dufrasne S, Roy M, Galvez M, Rosenblatt DS (2011) Experience over fifteen years with a protocol for predictive testing for Huntington disease. Mol Genet Metab 102(4):494\u2013504. https:\/\/doi.org\/10.1016\/j.ymgme.2010.12.001","journal-title":"Mol Genet Metab"},{"issue":"4","key":"10461_CR42","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s10897-012-9561-3","volume":"22","author":"L Guimaraes","year":"2013","unstructured":"Guimaraes L, Sequeiros J, Skirton H, Paneque M (2013) What counts as effective genetic counselling for presymptomatic testing in late-onset disorders? A study of the consultand\u2019s perspective. J Genet Couns 22(4):437\u2013447. https:\/\/doi.org\/10.1007\/s10897-012-9561-3","journal-title":"J Genet Couns"},{"issue":"1","key":"10461_CR43","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s10897-011-9383-8","volume":"21","author":"CSM Rodrigues","year":"2012","unstructured":"Rodrigues CSM, de Oliveira VZ, Camargo G, Osorio CMdS, de Castilhos RM, Saraiva-Pereira ML, Schuler-Faccini L, Jardim LB (2012) Presymptomatic testing for neurogenetic diseases in Brazil: assessing who seeks and who follows through with testing. J Genet Couns 21(1):101\u2013112. https:\/\/doi.org\/10.1007\/s10897-011-9383-8","journal-title":"J Genet Couns"},{"issue":"1 Suppl","key":"10461_CR44","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1590\/S1415-47572014000200012","volume":"37","author":"L Schuler-Faccini","year":"2014","unstructured":"Schuler-Faccini L, Osorio CM, Romariz F, Paneque M, Sequeiros J, Jardim LB (2014) Genetic counseling and presymptomatic testing programs for Machado-Joseph Disease: lessons from Brazil and Portugal. Genet Mol Bio 37(1 Suppl):263\u2013270","journal-title":"Genet Mol Bio"},{"issue":"6","key":"10461_CR45","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1111\/cge.12142","volume":"83","author":"T Cruz-Marino","year":"2013","unstructured":"Cruz-Marino T, Velazquez-Perez L, Gonzalez-Zaldivar Y, Aguilera-Rodriguez R, Velazquez-Santos M, Vazquez-Mojena Y, Estupinan-Rodriguez A, Laffita-Mesa JM, Reynaldo-Arminan R, Almaguer-Mederos LE, Paneque M (2013) The Cuban program for predictive testing of SCA2: 11 years and 768 individuals to learn from. Clin Genet 83(6):518\u2013524. https:\/\/doi.org\/10.1111\/cge.12142","journal-title":"Clin Genet"},{"issue":"5","key":"10461_CR46","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1002\/mgg3.238","volume":"5","author":"P Mandich","year":"2017","unstructured":"Mandich P, Lamp M, Gotta F, Gulli R, Iacometti A, Marchese R, Bellone E, Abbruzzese G, Ferrandes G (2017) 1993\u20132014: two decades of predictive testing for Huntington\u2019s disease at the Medical Genetics Unit of the University of Genoa. Mol Genet Genomic Med 5(5):473\u2013480. https:\/\/doi.org\/10.1002\/mgg3.238","journal-title":"Mol Genet Genomic Med"},{"issue":"2","key":"10461_CR47","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/ejhg.2012.147","volume":"21","author":"AK Hawkins","year":"2013","unstructured":"Hawkins AK, Creighton S, Hayden MR (2013) When access is an issue: exploring barriers to predictive testing for Huntington disease in British Columbia, Canada. Eur J Hum Genet 21(2):148\u2013153. https:\/\/doi.org\/10.1038\/ejhg.2012.147","journal-title":"Eur J Hum Genet"},{"issue":"11","key":"10461_CR48","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1038\/ejhg.2015.23","volume":"23","author":"M Paneque","year":"2015","unstructured":"Paneque M, Sequeiros J, Skirton H (2015) Quality issues concerning genetic counselling for presymptomatic testing: a European Delphi study. Eur J Hum Genet 23(11):1468\u20131472. https:\/\/doi.org\/10.1038\/ejhg.2015.23","journal-title":"Eur J Hum Genet"},{"issue":"6\u20137","key":"10461_CR49","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.neurol.2015.02.016","volume":"171","author":"S Clement","year":"2015","unstructured":"Clement S, Gargiulo M, Feingold J, Durr A (2015) Guidelines for presymptomatic testing for Huntington\u2019s disease: past, present and future in France. Revue Neurol (Paris) 171(6\u20137):572\u2013580. https:\/\/doi.org\/10.1016\/j.neurol.2015.02.016","journal-title":"Revue Neurol (Paris)"},{"key":"10461_CR50","doi-asserted-by":"publisher","first-page":"270","DOI":"10.4236\/ojgen.2013.34030","volume":"3","author":"S L\u00eado","year":"2013","unstructured":"L\u00eado S, Paneque M, Rocha J, Leite \u00c2, Sequeiros J (2013) Predictive testing for two neurodegenerative disorders (FAP and HD): a psychological point of view. Open J Genet 3:270\u2013279. https:\/\/doi.org\/10.4236\/ojgen.2013.34030","journal-title":"Open J Genet"},{"issue":"2","key":"10461_CR51","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1111\/cge.12058","volume":"83","author":"MC van Rij","year":"2013","unstructured":"van Rij MC, de Die-Smulders CEM, Bijlsma EK, de Wert GMWR, Geraedts JP, Roos RAC, Tibben A (2013) Evaluation of exclusion prenatal and exclusion preimplantation genetic diagnosis for Huntington\u2019s disease in the Netherlands. Clin Genet 83(2):118\u2013124. https:\/\/doi.org\/10.1111\/cge.12058","journal-title":"Clin Genet"},{"issue":"24","key":"10461_CR52","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1212\/WNL.0000000000002773","volume":"86","author":"M Benatar","year":"2016","unstructured":"Benatar M, Stanislaw C, Reyes E, Hussain S, Cooley A, Fernandez MC, Dauphin DD, Michon S-C, Andersen PM, Wuu J (2016) Presymptomatic ALS genetic counseling and testing: Experience and recommendations. Neurology 86(24):2295\u20132302. https:\/\/doi.org\/10.1212\/WNL.0000000000002773","journal-title":"Neurology"},{"issue":"3","key":"10461_CR53","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1159\/000479292","volume":"20","author":"A Leite","year":"2017","unstructured":"Leite A, Leite F, Dinis MAP (2017) Subjects at risk for genetic late-onset neurological diseases: objective knowledge. Public Health Genomics 20(3):158\u2013165. https:\/\/doi.org\/10.1159\/000479292","journal-title":"Public Health Genomics"},{"issue":"6","key":"10461_CR54","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1080\/19336896.2016.1254858","volume":"10","author":"K Clift","year":"2016","unstructured":"Clift K, Guthrie K, Klee EW, Boczek N, Cousin M, Blackburn P, Atwal P (2016) Familial Creutzfeldt-Jakob Disease: case report and role of genetic counseling in post mortem testing. Prion 10(6):502\u2013506","journal-title":"Prion"},{"issue":"3","key":"10461_CR55","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s10897-016-0056-5","volume":"26","author":"JS Goldman","year":"2017","unstructured":"Goldman JS, Huey ED, Thorne DZ (2017) The confluence of psychiatric symptoms and neurodegenerative disease: impact on genetic counseling. J Genet Couns 26(3):435\u2013441. https:\/\/doi.org\/10.1007\/s10897-016-0056-5","journal-title":"J Genet Couns"},{"issue":"1","key":"10461_CR56","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/s41431-018-0255-7","volume":"27","author":"A Bonnard","year":"2019","unstructured":"Bonnard A, Herson A, Gargiulo M, Durr A (2019) Reverse pre-symptomatic testing for Huntington disease: double disclosure when 25% at-risk children reveal the genetic status to their parent. Eur J Hum Genet 27(1):22\u201327. https:\/\/doi.org\/10.1038\/s41431-018-0255-7","journal-title":"Eur J Hum Genet"},{"issue":"3","key":"10461_CR57","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s12687-015-0226-4","volume":"6","author":"T Cruz-Marino","year":"2015","unstructured":"Cruz-Marino T, Vazquez-Mojena Y, Velazquez-Perez L, Gonzalez-Zaldivar Y, Aguilera-Rodriguez R, Velazquez-Santos M, Estupinan-Rodriguez A, Laffita-Mesa JM, Almaguer-Mederos LE, Paneque M (2015) SCA2 predictive testing in Cuba: challenging concepts and protocol evolution. J Commun Genet 6(3):265\u2013273. https:\/\/doi.org\/10.1007\/s12687-015-0226-4","journal-title":"J Commun Genet"},{"issue":"4","key":"10461_CR58","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1038\/ejhg.2011.202","volume":"20","author":"MC Van Rij","year":"2012","unstructured":"Van Rij MC, De Rademaeker M, Moutou C, Dreesen JCFM, De Rycke M, Liebaers I, Geraedts JPM, De Die-Smulders CEM, Viville S, on behalf of the BruMaStra PGDwg (2012) Preimplantation genetic diagnosis (PGD) for Huntington\u2019s disease: the experience of three European centres. Eur J Hum Genet 20(4):368\u2013375. https:\/\/doi.org\/10.1038\/ejhg.2011.202","journal-title":"Eur J Hum Genet"},{"issue":"5","key":"10461_CR59","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1007\/s10897-014-9715-6","volume":"23","author":"AL Smith","year":"2014","unstructured":"Smith AL, Teener JW, Callaghan BC, Harrington J, Uhlmann WR (2014) Amyotrophic lateral sclerosis in a patient with a family history of Huntington disease: genetic counseling challenges. J Genet Couns 23(5):725\u2013733. https:\/\/doi.org\/10.1007\/s10897-014-9715-6","journal-title":"J Genet Couns"},{"issue":"5","key":"10461_CR60","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1007\/s10897-017-0085-8","volume":"26","author":"A Ibisler","year":"2017","unstructured":"Ibisler A, Ocklenburg S, Stemmler S, Arning L, Epplen JT, Saft C, Hoffjan S (2017) Prospective evaluation of predictive DNA Testing for Huntington\u2019s Disease in a large German Center. J Genet Couns 26(5):1029\u20131040. https:\/\/doi.org\/10.1007\/s10897-017-0085-8","journal-title":"J Genet Couns"},{"issue":"1","key":"10461_CR61","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1177\/1363459316688516","volume":"22","author":"N Hagen","year":"2018","unstructured":"Hagen N (2018) The lived experience of Huntington\u2019s disease: a phenomenological perspective on genes, the body and the lived experience of a genetic disease. Health (London) 22(1):72\u201386. https:\/\/doi.org\/10.1177\/1363459316688516","journal-title":"Health (London)"},{"issue":"2","key":"10461_CR62","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1007\/s10897-010-9334-9","volume":"20","author":"R Butler","year":"2011","unstructured":"Butler R, Dwosh E, Beattie BL, Guimond C, Lombera S, Brief E, Illes J, Sadovnick AD (2011) Genetic counseling for early-onset familial Alzheimer disease in large Aboriginal kindred from a remote community in British Columbia: unique challenges and possible solutions. J Genet Couns 20(2):136\u2013142. https:\/\/doi.org\/10.1007\/s10897-010-9334-9","journal-title":"J Genet Couns"},{"issue":"4","key":"10461_CR63","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1007\/s10897-009-9222-3","volume":"18","author":"SR Riedijk","year":"2009","unstructured":"Riedijk SR, Niermeijer MFN, Dooijes D, Tibben A (2009) A decade of genetic counseling in frontotemporal dementia affected families: few counseling requests and much familial opposition to testing. J Genet Couns 18(4):350\u2013356. https:\/\/doi.org\/10.1007\/s10897-009-9222-3","journal-title":"J Genet Couns"},{"issue":"2","key":"10461_CR64","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3233\/JHD-170276","volume":"7","author":"R MacLeod","year":"2018","unstructured":"MacLeod R, Moldovan R, Stopford C, Ferrer-Duch M (2018) Genetic counselling and narrative practices: a model of support following a \u201cnegative\u201d predictive test for Huntington\u2019s Disease. J Huntingtons Dis 7(2):175\u2013183. https:\/\/doi.org\/10.3233\/JHD-170276","journal-title":"J Huntingtons Dis"},{"key":"10461_CR65","doi-asserted-by":"publisher","DOI":"10.1002\/jgc4.1229","author":"J Spiers","year":"2020","unstructured":"Spiers J, Smith JA, Ferrer-Duch M, Moldovan R, Roche J, MacLeod R (2020) Evaluating a genetic counseling narrative group session for people who have tested positive for the Huntington\u2019s disease expansion: an interpretative phenomenological analysis. J Genet Couns. https:\/\/doi.org\/10.1002\/jgc4.1229","journal-title":"J Genet Couns"},{"issue":"1","key":"10461_CR66","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s12687-019-00416-9","volume":"11","author":"C Stopford","year":"2020","unstructured":"Stopford C, Ferrer-Duch M, Moldovan R, MacLeod R (2020) Improving follow up after predictive testing in Huntington\u2019s disease: evaluating a genetic counselling narrative group session. J Commun Genet 11(1):47\u201358. https:\/\/doi.org\/10.1007\/s12687-019-00416-9","journal-title":"J Commun Genet"},{"issue":"1","key":"10461_CR67","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1111\/j.1399-0004.2008.01044.x","volume":"75","author":"MJ Futter","year":"2009","unstructured":"Futter MJ, Heckmann JM, Greenberg LJ (2009) Predictive testing for Huntington disease in a developing country. Clin Genet 75(1):92\u201397. https:\/\/doi.org\/10.1111\/j.1399-0004.2008.01044.x","journal-title":"Clin Genet"},{"issue":"Article 4","key":"10461_CR68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40734-017-0050-6","volume":"4","author":"J Charles","year":"2017","unstructured":"Charles J, Lessey L, Rooney J, Prokop I, Yearwood K, Da Breo H, Rooney P, Walker RH, Sobering AK (2017) Presentation and care of a family with Huntington disease in a resource-limited community. J Clin Mov Disord 4(Article 4):1\u20138. https:\/\/doi.org\/10.1186\/s40734-017-0050-6","journal-title":"J Clin Mov Disord"},{"issue":"5","key":"10461_CR69","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1002\/jgc4.1133","volume":"28","author":"M Withers","year":"2019","unstructured":"Withers M, Sayegh P, Rodriguez-Agudelo Y, Ernstrom K, Raman R, Montoya L, Zuno-Reyes A, Mosieri C, Matute E, Ringman JM (2019) A mixed-methods study of cultural beliefs about dementia and genetic testing among Mexicans and Mexican\u2013Americans at-risk for autosomal dominant Alzheimer\u2019s disease. J Genet Couns 28(5):921\u2013932. https:\/\/doi.org\/10.1002\/jgc4.1133","journal-title":"J Genet Couns"},{"issue":"4","key":"10461_CR70","doi-asserted-by":"publisher","first-page":"501","DOI":"10.3233\/JHD-190355","volume":"8","author":"TM Bardakjian","year":"2019","unstructured":"Bardakjian TM, Klapper J, Carey A, Wood J, Pauly M, Gasper K, Lawler K, Tran B, Bell Y, Zwil A, Gonzalez-Alegre P (2019) Addressing the value of multidisciplinary clinical care in Huntington\u2019s Disease: a snapshot of a new Huntington\u2019s Disease Center. J Huntingtons Dis 8(4):501\u2013507. https:\/\/doi.org\/10.3233\/JHD-190355","journal-title":"J Huntingtons Dis"},{"issue":"4","key":"10461_CR71","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1097\/GIM.0b013e318204d004","volume":"13","author":"JH Fanos","year":"2011","unstructured":"Fanos JH, Gronka S, Wuu J, Stanislaw C, Andersen PM, Benatar M (2011) Impact of presymptomatic genetic testing for familial amyotrophic lateral sclerosis. Genet Med 13(4):342\u2013348. https:\/\/doi.org\/10.1097\/GIM.0b013e318204d004","journal-title":"Genet Med"},{"issue":"3\u20134","key":"10461_CR72","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1080\/21678421.2019.1582670","volume":"20","author":"H Klepek","year":"2019","unstructured":"Klepek H, Nagaraja H, Goutman SA, Quick A, Kolb SJ, Roggenbuck J (2019) Lack of consensus in ALS genetic testing practices and divergent views between ALS clinicians and patients. Amyotroph Lateral Scler Frontotemporal Degener 20(3\u20134):216\u2013221. https:\/\/doi.org\/10.1080\/21678421.2019.1582670","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"issue":"6","key":"10461_CR73","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1038\/gim.2012.149","volume":"15","author":"AKH Hawkins Virani","year":"2013","unstructured":"Hawkins Virani AKH, Creighton SM, Hayden MR (2013) Developing a comprehensive, effective patient-friendly website to enhance decision making in predictive testing for Huntington disease. Genet Med 15(6):466\u2013472. https:\/\/doi.org\/10.1038\/gim.2012.149","journal-title":"Genet Med"},{"issue":"4","key":"10461_CR74","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/s10897-015-9831-y","volume":"24","author":"P Mandich","year":"2015","unstructured":"Mandich P, Mantero V, Verdiani S, Gotta F, Caponnetto C, Bellone E, Ferrandes G, Origone P (2015) Complexities of genetic counseling for ALS: a case of two siblings with discordant genetic test results. J Genet Couns 24(4):553\u2013557. https:\/\/doi.org\/10.1007\/s10897-015-9831-y","journal-title":"J Genet Couns"},{"issue":"3","key":"10461_CR75","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1007\/s10897-017-0088-5","volume":"26","author":"V Mantero","year":"2017","unstructured":"Mantero V, Tarlarini C, Aliprandi A, Lauria G, Rigamonti A, Abate L, Origone P, Mandich P, Penco S, Salmaggi A (2017) Genetic counseling dilemmas for a patient with sporadic amyotrophic lateral sclerosis, frontotemporal degeneration and Parkinson\u2019s Disease. J Genet Couns 26(3):442\u2013446. https:\/\/doi.org\/10.1007\/s10897-017-0088-5","journal-title":"J Genet Couns"},{"issue":"10","key":"10461_CR76","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1136\/medethics-2016-103400","volume":"42","author":"Z Stark","year":"2016","unstructured":"Stark Z, Wallace J, Gillam L, Burgess M, Delatycki MB (2016) Predictive genetic testing for neurodegenerative conditions: how should conflicting interests within families be managed? J Med Ethics 42(10):640\u2013642. https:\/\/doi.org\/10.1136\/medethics-2016-103400","journal-title":"J Med Ethics"},{"issue":"5","key":"10461_CR77","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1097\/wco.0000000000000594","volume":"31","author":"CV Ly","year":"2018","unstructured":"Ly CV, Miller TM (2018) Emerging antisense oligonucleotide and viral therapies for amyotrophic lateral sclerosis. Curr Opin Neurol 31(5):648\u2013654. https:\/\/doi.org\/10.1097\/wco.0000000000000594","journal-title":"Curr Opin Neurol"},{"issue":"2","key":"10461_CR78","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1093\/brain\/awz328","volume":"143","author":"AC Silva","year":"2019","unstructured":"Silva AC, Lobo DD, Martins IM, Lopes SM, Henriques C, Duarte SP, Dodart J-C, Nobre RJ, Pereira de Almeida L (2019) Antisense oligonucleotide therapeutics in neurodegenerative diseases: the case of polyglutamine disorders. Brain 143(2):407\u2013429. https:\/\/doi.org\/10.1093\/brain\/awz328","journal-title":"Brain"},{"issue":"4","key":"10461_CR79","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1111\/scs.12212","volume":"29","author":"M Rothing","year":"2015","unstructured":"Rothing M, Malterud K, Frich JC (2015) Family caregivers\u2019 views on coordination of care in Huntington\u2019s disease: a qualitative study. Scand J Caring Sci 29(4):803\u2013809. https:\/\/doi.org\/10.1111\/scs.12212","journal-title":"Scand J Caring Sci"},{"issue":"3","key":"10461_CR80","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s00401-012-1029-x","volume":"124","author":"A Sieben","year":"2012","unstructured":"Sieben A, Van Langenhove T, Engelborghs S, Martin JJ, Boon P, Cras P, De Deyn PP, Santens P, Van Broeckhoven C, Cruts M (2012) The genetics and neuropathology of frontotemporal lobar degeneration. Acta Neuropathol 124(3):353\u2013372. https:\/\/doi.org\/10.1007\/s00401-012-1029-x","journal-title":"Acta Neuropathol"},{"issue":"4","key":"10461_CR81","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/sj.ejhg.5201774","volume":"15","author":"M Decruyenaere","year":"2007","unstructured":"Decruyenaere M, Evers-Kiebooms G, Boogaerts A, Philippe K, Demyttenaere K, Dom R, Vandenberghe W, Fryns JP (2007) The complexity of reproductive decision-making in asymptomatic carriers of the Huntington mutation. Eur J Hum Genet 15(4):453\u2013462. https:\/\/doi.org\/10.1038\/sj.ejhg.5201774","journal-title":"Eur J Hum Genet"},{"issue":"1\u20132","key":"10461_CR82","doi-asserted-by":"publisher","first-page":"114","DOI":"10.3109\/21678421.2014.951945","volume":"16","author":"DEH Hartzfeld","year":"2015","unstructured":"Hartzfeld DEH, Siddique N, Victorson D, O\u2019Neill S, Kinsley L, Siddique T (2015) Reproductive decision-making among individuals at risk for familial amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener 16(1\u20132):114\u2013119. https:\/\/doi.org\/10.3109\/21678421.2014.951945","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"issue":"4","key":"10461_CR83","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/ejhg.2014.116","volume":"23","author":"H Skirton","year":"2015","unstructured":"Skirton H, Cordier C, Ingvoldstad C, Taris N, Benjamin C (2015) The role of the genetic counsellor: a systematic review of research evidence. Eur J Hum Genet 23(4):452\u2013458. https:\/\/doi.org\/10.1038\/ejhg.2014.116","journal-title":"Eur J Hum Genet"},{"issue":"5","key":"10461_CR84","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1086\/302374","volume":"64","author":"EW Almqvist","year":"1999","unstructured":"Almqvist EW, Bloch M, Brinkman R, Craufurd D, Hayden MR (1999) A worldwide assessment of the frequency of suicide, suicide attempts, or psychiatric hospitalization after predictive testing for Huntington disease. Am J Hum Gen 64(5):1293\u20131304. https:\/\/doi.org\/10.1086\/302374","journal-title":"Am J Hum Gen"},{"issue":"1","key":"10461_CR85","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1002\/ajmg.b.32453","volume":"174","author":"MA Nance","year":"2017","unstructured":"Nance MA (2017) Genetic counseling and testing for Huntington\u2019s disease: a historical review. Am J Med Genet Part B Neuropsychiatr Genet 174(1):75\u201392. https:\/\/doi.org\/10.1002\/ajmg.b.32453","journal-title":"Am J Med Genet Part B Neuropsychiatr Genet"},{"issue":"1","key":"10461_CR86","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1089\/gtmb.2011.0023","volume":"16","author":"M Paneque","year":"2012","unstructured":"Paneque M, Sequeiros J, Skirton H (2012) Quality assessment of genetic counseling process in the context of presymptomatic testing for late-onset disorders: a thematic analysis of three review articles. Genet Test Mol Biomarkers 16(1):36\u201345. https:\/\/doi.org\/10.1089\/gtmb.2011.0023","journal-title":"Genet Test Mol Biomarkers"},{"issue":"8","key":"10461_CR87","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1001\/jamaneurol.2020.1452","volume":"77","author":"BR Bloem","year":"2020","unstructured":"Bloem BR, Dorsey ER, Okun MS (2020) The coronavirus disease 2019 crisis as catalyst for telemedicine for chronic neurological disorders. JAMA Neurol 77(8):927\u2013928. https:\/\/doi.org\/10.1001\/jamaneurol.2020.1452","journal-title":"JAMA Neurol"},{"issue":"3","key":"10461_CR88","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1097\/JXX.0000000000000373","volume":"32","author":"S Rhoads","year":"2020","unstructured":"Rhoads S, Rakes AL (2020) Telehealth technology: reducing barriers for rural residents seeking genetic counseling. J Am Assoc Nurse Pract 32(3):190\u2013192","journal-title":"J Am Assoc Nurse Pract"},{"issue":"4","key":"10461_CR89","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1007\/s10897-014-9784-6","volume":"24","author":"M Paneque","year":"2015","unstructured":"Paneque M, Mendes A, Guimaraes L, Sequeiros J, Skirton H (2015) Genetics Health Professionals\u2019 views on quality of genetic counseling service provision for presymptomatic testing in late-onset neurological diseases in Portugal: core components, specific challenges and the need for assessment tools. J Genet Couns 24(4):616\u2013625. https:\/\/doi.org\/10.1007\/s10897-014-9784-6","journal-title":"J Genet Couns"},{"issue":"4","key":"10461_CR90","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1212\/wnl.0000000000000061","volume":"82","author":"DJ Hensman Moss","year":"2014","unstructured":"Hensman Moss DJ, Poulter M, Beck J, Hehir J, Polke JM, Campbell T, Adamson G, Mudanohwo E, McColgan P, Haworth A, Wild EJ, Sweeney MG, Houlden H, Mead S, Tabrizi SJ (2014) C9orf72 expansions are the most common genetic cause of Huntington disease phenocopies. Neurology 82(4):292\u2013299. https:\/\/doi.org\/10.1212\/wnl.0000000000000061","journal-title":"Neurology"},{"issue":"5","key":"10461_CR91","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1002\/mds.21915","volume":"23","author":"EJ Wild","year":"2008","unstructured":"Wild EJ, Mudanohwo EE, Sweeney MG, Schneider SA, Beck J, Bhatia KP, Rossor MN, Davis MB, Tabrizi SJ (2008) Huntington\u2019s disease phenocopies are clinically and genetically heterogeneous. Mov Disord 23(5):716\u2013720. https:\/\/doi.org\/10.1002\/mds.21915","journal-title":"Mov Disord"},{"issue":"6","key":"10461_CR92","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1007\/s10897-018-0274-0","volume":"27","author":"KM Stuttgen","year":"2018","unstructured":"Stuttgen KM, Bollinger JM, Dvoskin RL, McCague A, Shpritz B, Brandt J, Mathews DJH (2018) Perspectives on genetic testing and return of results from the first cohort of presymptomatically tested individuals at risk of Huntington Disease. J Genet Couns 27(6):1428\u20131437. https:\/\/doi.org\/10.1007\/s10897-018-0274-0","journal-title":"J Genet Couns"},{"issue":"3","key":"10461_CR93","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1097\/JNN.0b013e3181d4a37f","volume":"42","author":"RR Schwartz","year":"2010","unstructured":"Schwartz RR (2010) Ripples from a stone skipping across the lake: a narrative approach to the meaning of Huntington\u2019s disease. J Neurosci Nurs 42(3):157\u2013168","journal-title":"J Neurosci Nurs"},{"issue":"1","key":"10461_CR94","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3233\/JHD-180314","volume":"8","author":"A Tibben","year":"2019","unstructured":"Tibben A, Dondorp WJ, de Wert GM, de Die-Smulders CE, Losekoot M, Bijlsma EK (2019) Risk assessment for Huntington\u2019s disease for (future) offspring requires offering preconceptional CAG analysis to both partners. J Huntingtons Dis 8(1):71\u201378. https:\/\/doi.org\/10.3233\/JHD-180314","journal-title":"J Huntingtons Dis"},{"issue":"6","key":"10461_CR95","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1111\/cge.12893","volume":"91","author":"KA Quaid","year":"2017","unstructured":"Quaid KA, Eberly SW, Kayson-Rubin E, Oakes D, Shoulson I, Huntington Study Group PI, Coordinators (2017) Factors related to genetic testing in adults at risk for Huntington disease: the prospective Huntington at-risk observational study (PHAROS). Clin Genet 91(6):824\u2013831. https:\/\/doi.org\/10.1111\/cge.12893","journal-title":"Clin Genet"},{"issue":"1","key":"10461_CR96","first-page":"125","volume":"34","author":"\u00c2 Leite","year":"2017","unstructured":"Leite \u00c2, Dinis MAP, Sequeiros J, Pa\u00fal C (2017) Motivation to perform presymptomatic testing in Portuguese subjects at-risk for late-onset genetic diseases. Interdisciplinaria 34(1):125\u2013140","journal-title":"Interdisciplinaria"},{"issue":"1","key":"10461_CR97","doi-asserted-by":"publisher","first-page":"e1026","DOI":"10.1002\/mgg3.1026","volume":"8","author":"CC Eno","year":"2020","unstructured":"Eno CC, Barton SK, Dorrani N, Cederbaum SD, Deignan JL, Grody WW (2020) Confidential genetic testing and electronic health records: a survey of current practices among Huntington disease testing centers. Mol Genet Genomic Med 8(1):e1026. https:\/\/doi.org\/10.1002\/mgg3.1026","journal-title":"Mol Genet Genomic Med"},{"issue":"1","key":"10461_CR98","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1002\/mdc3.12859","volume":"7","author":"S Cahn","year":"2020","unstructured":"Cahn S, Rosen A, Wilmot G (2020) Spinocerebellar ataxia patient perceptions regarding reproductive options. Mov Disord Clin Pract 7(1):37\u201344. https:\/\/doi.org\/10.1002\/mdc3.12859","journal-title":"Mov Disord Clin Pract"},{"issue":"10","key":"10461_CR99","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1212\/WNL.0000000000003686","volume":"88","author":"A Vajda","year":"2017","unstructured":"Vajda A, McLaughlin RL, Heverin M, Thorpe O, Abrahams S, Al-Chalabi A, Hardiman O (2017) Genetic testing in ALS: a survey of current practices. Neurology 88(10):991\u2013999. https:\/\/doi.org\/10.1212\/WNL.0000000000003686","journal-title":"Neurology"},{"issue":"5\u20136","key":"10461_CR100","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1080\/21678421.2019.1588904","volume":"20","author":"A Crook","year":"2019","unstructured":"Crook A, McEwen A, Fifita JA, Zhang K, Kwok JB, Halliday G, Blair IP, Rowe DB (2019) The C9orf72 hexanucleotide repeat expansion presents a challenge for testing laboratories and genetic counseling. Amyotroph Lateral Scler Frontotemporal Degener 20(5\u20136):310\u2013316. https:\/\/doi.org\/10.1080\/21678421.2019.1588904","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"issue":"4","key":"10461_CR101","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1007\/s11845-018-1784-3","volume":"187","author":"DA Olszewska","year":"2018","unstructured":"Olszewska DA, McVeigh T, Fallon EM, Pastores GM, Lynch T (2018) The benefits of a neurogenetics clinic in an adult Academic Teaching Hospital. Ir J Med Sci 187(4):1073\u20131076. https:\/\/doi.org\/10.1007\/s11845-018-1784-3","journal-title":"Ir J Med Sci"},{"issue":"8","key":"10461_CR102","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1038\/jhg.2013.34","volume":"58","author":"K Tanaka","year":"2013","unstructured":"Tanaka K, Sekijima Y, Yoshida K, Tamai M, Kosho T, Sakurai A, Wakui K, Ikeda S-i, Fukushima Y (2013) Follow-up nationwide survey on predictive genetic testing for late-onset hereditary neurological diseases in Japan. J Hum Genet 58(8):560\u2013563. https:\/\/doi.org\/10.1038\/jhg.2013.34","journal-title":"J Hum Genet"},{"issue":"2","key":"10461_CR103","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s10897-010-9330-0","volume":"20","author":"ELR Alexander","year":"2011","unstructured":"Alexander ELR, Butler RK, Guimond C, Butler B, Sadovnick AD (2011) Accuracy of reported family history and effectiveness of medical record requests in genetic counseling for Alzheimer disease. J Genet Couns 20(2):129\u2013135. https:\/\/doi.org\/10.1007\/s10897-010-9330-0","journal-title":"J Genet Couns"},{"issue":"Article 895","key":"10461_CR104","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fgene.2019.00895","volume":"10","author":"M Schwartz","year":"2019","unstructured":"Schwartz M, Brandel JP, Babonneau ML, Boucher C, Schaerer E, Haik S, Laplanche JL, Gargiulo M, Durr A (2019) Genetic testing in prion disease: psychological consequences of the decisions to know or not to know. Front Genet 10(Article 895):1\u20138. https:\/\/doi.org\/10.3389\/fgene.2019.00895","journal-title":"Front Genet"},{"issue":"4","key":"10461_CR105","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/s10897-011-9422-5","volume":"21","author":"M Yanoov-Sharav","year":"2012","unstructured":"Yanoov-Sharav M, Leshinsky-Silver E, Cohen S, Vinkler C, Michelson M, Lerman-Sagie T, Ginzberg M, Sadeh M, Lev D (2012) Genetic counseling and testing for FSHD (facioscapulohumeral muscular dystrophy) in the Israeli population. J Genet Couns 21(4):557\u2013563. https:\/\/doi.org\/10.1007\/s10897-011-9422-5","journal-title":"J Genet Couns"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-021-10461-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-021-10461-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-021-10461-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T22:34:21Z","timestamp":1744151661000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-021-10461-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,1]]},"references-count":105,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["10461"],"URL":"https:\/\/doi.org\/10.1007\/s00415-021-10461-5","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,1]]},"assertion":[{"value":"9 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"On behalf of all authors, the corresponding author states that there is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}